NHS managers who silence whistleblowers to be banned from senior health roles
Legislation is set to be put forward to Parliament next year to introduce professional standards and regulation of NHS managers.
Tens of thousands of clinical and non-clinical managers work in the NHS but there is currently no regulatory framework specifically for managers, as there is for doctors and nurses.
Health Secretary Wes Streeting said the reforms will 'slam the door in the face of unsuitable managers'.
Mr Streeting added: 'I'm determined to create a culture of honesty and openness in the NHS where whistleblowers are protected, and that demands tough enforcement.
'If you silence whistleblowers, you will never work in the NHS again.
'We've got to create the conditions where staff are free to come forward and sound the alarm when things go wrong. Protecting the reputation of the NHS should never be put before protecting patient safety.
'Most NHS leaders are doing a fantastic job, but we need to stop the revolving door that allows managers sacked for misconduct or incompetence to be quietly moved to another well-paid role in another part of the NHS.'
DHSC said a public consultation launched in November last year received more than 4,900 contributions on ways in which managers and leaders could be regulated.
The statutory barring system will be for board-level directors and their direct reports within NHS bodies.
Further legislation will set out new statutory powers for the Health and Care Professions Council to disbar NHS leaders in senior roles who have committed serious misconduct.
Separate NHS England professional standards for managers will establish a 'consistent, national set of expectations about NHS management and leadership competency and conduct', DHSC said.
Tom Kark KC, author of the Kark Review into the effectiveness of the fit and proper person test within the NHS, said: 'I am pleased that the recommendation made in my report into the application of the NHS fit and proper person test to create a power to disqualify board directors found guilty of serious misconduct is being implemented.
'Along with the ongoing implementation of my other recommendations for improving board competence, this is a positive move to strengthen management in the NHS by weeding out poor leadership.
'This is good news for whistleblowers and those looking for accountability in senior management which has long been lacking.'
Rachel Power, chief executive of the Patients Association, said patients expect NHS managers 'to be held to the same high standards as clinical staff, and that should include consistent regulation'.
Ms Power added: 'A clear, fair process to prevent those who commit serious misconduct from returning to senior roles will be an important step forward, and it's vital that patient involvement continues to shape proposals as further regulation is considered.'
Saffron Cordery, deputy chief executive of NHS Providers, said the membership organisation for hospital, mental health, community and ambulance services thought 'only 'fit and proper' people should be running NHS services'.
Ms Cordery added: 'Many big, complex NHS trusts employ thousands of people therefore we want to attract the very best to lead them.
'So we welcome the Government's commitment to developing and accrediting managers alongside proposals for disbarring those whose performance falls short.'
Sam Allen, NHS national director for leadership and management, said: 'Managers will welcome this new regulatory framework, as part of the broader package of actions set out in the plan to attract, develop, and retain the best possible leaders for the NHS of today and tomorrow.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Rhyl Journal
3 hours ago
- Rhyl Journal
Patients sought for new NHS trial for brain cancer after man sees tumour vanish
The NHS study will recruit 16 people over an 18-month period and has been set up in memory of Baroness Margaret McDonagh, who died of the disease. People diagnosed with deadly glioblastoma will receive immunotherapy with the drug ipilimumab before undergoing standard treatment, when their immune system is at its strongest. The trial, from University College London Hospital's National Hospital for Neurology and Neurosurgery, follows a previous one on the same drug which closed because of lack of recruitment. One patient from that trial, Ben Trotman, is still showing no signs of glioblastoma following the treatment – well over two years since he got the drug in a world first. Most people with glioblastoma die within 12-18 months. Mr Trotman was diagnosed with glioblastoma in October 2022, when he was 40. Now aged 43 and two years and eight months on from having the treatment, his scans are clear and there are no signs of tumour. Consultant medical oncologist, Dr Paul Mulholland, who is leading the new trial and treated Mr Trotman, said: 'It is very unusual to have a clear scan with glioblastoma, especially when he didn't have the follow-up surgery that had been planned to remove all of the tumour that was initially visible on scans. 'We hope that the immunotherapy and follow-up treatment Ben has had will hold his tumour at bay – and it has so far, which we are delighted to see.' Mr Trotman got married to Emily two months after the immunotherapy treatment and in April, his daughter Mabel was born. Mrs Trotman said: 'Getting this diagnosis was the most traumatic experience. We were grappling with the fact that Ben had gone from being apparently perfectly healthy to having months to live. 'Had we not met Dr Mulholland, that would have been it for us. We felt we had a lucky break in an otherwise devastating situation.' Mr Trotman went on to have the current standard treatment of radiotherapy and chemotherapy. He has quarterly scans, which continue to be clear. Mr Trotman said: 'We obviously don't know what the future holds but having had the immunotherapy treatment and getting these encouraging scan results has given Emily and I a bit of hope. 'We are focused on rebuilding the life we thought we had lost and enjoying being parents.' Dame Siobhain McDonagh MP led a fundraising campaign to raise more than £1 million to cover the costs of the new trial. Her sister, Baroness McDonagh, died from glioblastoma in 2023. Dame Siobhain said: 'My beloved sister Margaret was appalled to discover that there had been no advances in brain cancer treatment for decades when she was diagnosed with glioblastoma. 'Changing this was Margaret's final campaign and one that I have continued in her memory. 'I am so grateful to the many people who knew and respected Margaret who have come together and helped to raise funds and campaign for this new trial that we are calling Margaret's Trial.' Dr Paul Mulholland said: 'When I met Margaret she said to me 'what can I do to support you to cure this disease?'. 'I am incredibly grateful to her and to Siobhain whose campaigning and fundraising in her sister's memory has led to this new clinical trial opening for patients with this most aggressive form of brain cancer that has such a poor prognosis, with most patients surviving just nine months after diagnosis. 'The crucial element of this trial is that patients will have their immune system boosted by the drug before they have any other treatment, when they are fit and well enough to tolerate the immunotherapy. 'We're taking everything we have learned from previous trials into this new study and we are already planning follow-on trials. 'My aim is to find a cure for glioblastoma.' The National Brain Appeal is currently funding two posts in support of Dr Mulholland's research. Treatment will take place at the NIHR UCLH's Clinical Research Facility and at the National Hospital for Neurology and Neurosurgery. Patients interested in the new Win-Glio trial should discuss it with their consultant.
Rhyl Journal
3 hours ago
- Rhyl Journal
Almost half of people do not think 10-year plan will boost GP access
More than four in 10 also believe the 10-year plan will make no difference or will not improve waiting times in A&E. However, there is huge support for some of the ideas included in the blueprint, with the overwhelming majority backing the creation of neighbourhood health centres, the expansion of the NHS app and more mental health support in schools and colleges. The 10-year health plan was unveiled by Prime Minister Sir Keir Starmer earlier this month, and set out a series of shifts to bring care much closer to people's homes, reducing the reliance on hospitals and A&E. Key reforms include an enhanced NHS app, giving patients more control over their care, new neighbourhood health centres open six days a week and at least 12 hours a day, and new laws on food and alcohol to prevent ill health. A survey of 1,023 adults in Britain, conducted by Ipsos for the PA news agency, asked people how they think the plan will impact access to healthcare, such as getting a GP appointment, A&E waiting times and waiting times for routine hospital treatment. Some 35% said the plan will have no impact on getting a GP appointment, while 14% believe it will make things harder. This compares with the 29% of people who said they think it will make getting an appointment easier. More than a third (37%) said it will make no difference to waiting times in emergency departments, while almost one in 10 (9%), said they believe it could worsen waiting times, compared with 30% who said it will improve them. Meanwhile, 31% said the plan will have no impact on waiting times for hospital treatment, 11% believe the plan will worsen waiting times and 34% said they think the measures will help. However, a number of proposals outlined in the plan were strongly backed by the public. Some 84% said they supported the creation of a single patient record, while 78% backed the creation of neighbourhood health centres, 73% support the expansion of the NHS app and 72% are in favour of more mental health support in schools and colleges. However, more than a quarter (27%) of people do not support making hospitals fully AI enabled, compared with 44% who would back the move. Almost one in five (18%) said they would not support so-called 'patient power payments', which would allow patients to hold back some of the payment for their care if they are not satisfied, while 42% would support the measure. Some proposals aimed at helping people to lead healthier lives were also strongly supported. A ban on the sale of high-caffeine energy drinks was backed by 78% of people, while 69% back plans to restrict junk food advertising. However, almost one in five (18%) tended to disagree with measures that could see alcoholic drinks labelled with nutritional information, although 57% backed the move. One in four people think the measures included in the plan will make no difference to patients, the poll found. Almost one in 10 (9%) said they think the changes will make things worse, while 35% believe it will improve the health service. A similar proportion, 23%, said the 10-year health plan will make no difference to NHS staff, while 13% said it could make things worse and 33% believe it will have a positive effect. A Department of Health and Social Care spokesperson said: 'We're getting on with the job of delivering for patients, with NHS waiting lists falling by 260,000 since July 2024, delivering more than 4.6 million additional appointments since the general election and recruiting over 1,900 extra GPs to fix the front door of the NHS. 'Backed by an additional £29 billion, our 10-year health plan will seize the opportunities provided by new technology, medicines and innovation to deliver better care for all patients, no matter where they live or how much they earn, and better value for taxpayers. 'It is no surprise the plan is popular with patients, it was the result of the biggest conversation with staff, patients and the public since the formation of the NHS, with more than a quarter of a million contributions.'
Rhyl Journal
3 hours ago
- Rhyl Journal
Chris Packham backs call for delayed report into autistic deaths to be published
Signatories including broadcaster Chris Packham – who has spoken about being autistic – demanded the long-awaited report be published as soon as Parliament returns from its summer break. He is among campaigners who have written to Health Secretary Wes Streeting to say the country is 'standing by year after year while vulnerable people die'. The latest Learning from lives and deaths report (LeDeR) – expected to show data for 2023 – was due to be published around November last year but it is understood it has been held up over 'practical data issues'. The LeDeR programme was established in 2015 in an effort to review the deaths of people with a learning disability and autistic people in England. Annual reports are aimed at summarising their lives and deaths with the aim of learning from what happened, improving care, reducing health inequalities and preventing people with a learning disability and autistic people from early deaths. In the letter to Mr Streeting, signed by various groups including charities Autism Action and Mencap as well as bereaved families, the delay to the latest report was branded 'unacceptable'. They said: 'It took at least 17 years for the Government to establish this vital initiative after the 1998 finding that people with learning disabilities were 58 times more likely to die before the age of 50 than the general population. 'Although it was established to 'get to the bottom of why people with learning disabilities typically die much earlier than average, and to inform a strategy to reduce this inequality,' 10 years later – too many people are still dying premature, preventable deaths. 'In response, the Government is showing a shocking lack of urgency and has let the only discernible tool to understand and act on these deaths be caught up in delay and bureaucracy.' The most recent report, which showed data for 2022, confirmed care and outcomes for people with learning disabilities are still often below acceptable standards compared with the general population. Of the 2,054 adults with a learning disability who died that year and had a completed recorded underlying cause of death, 853 (42%) had deaths classified as avoidable. This was down on the 2021 figure of 50% of avoidable deaths among adults with a learning disability, but was 'significantly higher' than the percentage for the general population across Great Britain, which was 22.8% in 2020 – the latest data available at that time. Last month, the parents of an autistic teenager who died after being prescribed medication against his and his parents' wishes hailed the publication of guidance they hope will safeguard others as a 'significant milestone'. A report in 2020 found 18-year-old Oliver McGowan's death four years earlier at Southmead Hospital in Bristol was 'potentially avoidable'. He died in 2016 after being given the antipsychotic Olanzapine and contracting neuroleptic malignant syndrome (NMS) – a rare side-effect of the drug. An independent review later found that the fit and healthy teenager's death was 'potentially avoidable' and his parents, Paula and Tom McGowan, said their son died 'as a result of the combined ignorance and arrogance of doctors' who treated him. In June, his parents – who have campaigned since his death for improvements in the system – welcomed the publication of new guidance aimed at ensuring safer, more personalised care for people with a learning disability and autistic people. Learning disability charity Mencap described the delay to the latest LeDeR report as 'disappointing and worrying', and said the Government must 'not shy away from the uncomfortable truth that for many years the healthcare system has failed people who are already marginalised in so many ways'. Autism Action chief executive Tom Purser accused the Government of 'systemically devaluing the lives of autistic people and those with learning disabilities' by delaying the long-awaited annual report and giving campaigners and families 'empty reassurances'. He added: 'There must be systemic changes in the way this information is collected, recorded, shared and acted upon – and it needs to be accountable and written into law. We are calling on this data to be published annually and independently of the Government and the NHS. 'Without these changes the Government has nothing to learn from and more vulnerable lives are at stake.' A Department of Health and Social Care spokesperson said: 'We inherited a situation where the care of people with a learning disability and autistic people was not good enough and we recently published a code of practice on training to make sure staff have the right knowledge and skills to provide safe and informed care. 'We are committed to improving care for people with a learning disability and autistic people. The Learning from Lives and Deaths report will help identify key improvements needed to tackle health disparities and prevent avoidable deaths.'
